HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Douglas J. Mathisen John C. Wain Cameron D. Wright Hermes C. Grillo Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hagan, M. P. Articles by Grillo, H. C. Search for Related Content PubMed PubMed Citation Articles by Hagan, M. P. Articles by Grillo, H. C.

J Thorac Cardiovasc Surg 1999;117:1086-1094
© 1999 Mosby, Inc.

GENERAL THORACIC SURGERY

SUPERIOR SULCUS LUNG TUMORS: IMPACT OF LOCAL CONTROL ON SURVIVAL

From the Departments of Radiation Oncology^a and Thoracic Surgery,^b Massachusetts General Hospital, Boston, Mass.

Received for publication March 12, 1998. Revisions requested May 22, 1998. Revisions received Jan 18, 1999. Accepted for publication Feb 12, 1999. Address for reprints: Michael P. Hagan, MD, Department of Radiation Oncology, Medical College of Virginia, PO Box 980058, 401 College St, Richmond, VA 23298.

Objectives: Our goal was to assess patient survival and response to treatment for superior sulcus tumors treated with combined radiation therapy and surgery when possible, or with radiation alone when surgery was not possible.
Methods: Seventy-three patients were treated for primary non–small cell carcinoma of the superior pulmonary sulcus. Thirty-four patients received combined resection and irradiation. Thirty-nine patients who had extensive primary disease, distant metastases, or who were medically unfit for surgery were treated with radiation alone. Thirty-one patients (91%) assigned to the resection/irradiation group completed treatment. Combined therapy patients routinely received 40 Gy before the operation, with additional postoperative irradiation based on the surgical findings.
Results: Overall survival at 5 years was 19% and disease-specific survival was 20% for all patients. Overall survival and disease-specific survival at 5 years for the resection/irradiation group were 33% and 38%, respectively. Significant indicators of poor prognosis included unresected primary disease, low performance score, T4 stage, or positive node status. Eighty-two percent of the patients who received irradiation alone were treated with palliative intent. Freedom from local-regional progression, achieved initially in 66% of these patients, was associated with a median survival of 8 months. Median survival for 7 patients considered for definitive irradiation was 25 months. During the first 18 months, distant failures occurred in approximately 35% of patients in each treatment group.
Conclusions: Selection of medically fit patients with resectable disease for combined surgery and aggressive radiation therapy resulted in a high likelihood of local control. Overall survival for the resection/irradiation group was significantly poorer for patients with T4 stage, nodal disease, or Horner's syndrome. Distant metastases eventually developed in 56% of patients undergoing resection. Median survival in the resection/irradiation group was significantly prolonged for those patients who could tolerate high-dose radiation treatment.

This article has been cited by other articles:

				M. Tamura, M. A. Hoda, and W. Klepetko Current treatment paradigms of superior sulcus tumours Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 747 - 753. [Abstract] [Full Text] [PDF]

				V. W. Rusch, D. J. Giroux, M. J. Kraut, J. Crowley, M. Hazuka, T. Winton, D. H. Johnson, L. Shulman, F. Shepherd, C. Deschamps, et al. Induction Chemoradiation and Surgical Resection for Superior Sulcus Non-Small-Cell Lung Carcinomas: Long-Term Results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J. Clin. Oncol., January 20, 2007; 25(3): 313 - 318. [Abstract] [Full Text] [PDF]

				C. C.M. Pitz, A. B. de la Riviere, H. A. van Swieten, V. A.M. Duurkens, J.-W. J. Lammers, and J. M.M. van den Bosch Surgical treatment of Pancoast tumours Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 202 - 208. [Abstract] [Full Text] [PDF]

				A. N. van Geel, P. P. Jansen, R. J. van Klaveren, and J. R. M. van der Sijp High Relapse-Free Survival After Preoperative and Intraoperative Radiotherapy and Resection for Sulcus Superior Tumors Chest, November 1, 2003; 124(5): 1841 - 1846. [Abstract] [Full Text] [PDF]

				C. D. Wright, M. T. Menard, J. C. Wain, D. M. Donahue, H. C. Grillo, T. J. Lynch, N. C. Choi, and D. J. Mathisen Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus Ann. Thorac. Surg., May 1, 2002; 73(5): 1541 - 1544. [Abstract] [Full Text] [PDF]

				V. W. Rusch, D. J. Giroux, M. J. Kraut, J. Crowley, M. Hazuka, D. Johnson, M. Goldberg, F. Detterbeck, F. Shepherd, R. Burkes, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 472 - 483. [Abstract] [Full Text] [PDF]

				F. G. Pearson Non-small Cell Lung Cancer* : Role of Surgery for Stages I-III Chest, December 1, 1999; 116 (2009): 500S - 503S. [Abstract] [Full Text] [PDF]

				P. Dartevelle and P. Macchiarini Surgical Management of Superior Sulcus Tumors Oncologist, October 1, 1999; 4(5): 398 - 407. [Abstract] [Full Text]